🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

18,54 USD

Máx. histórico

178,74

2142 días

Split 1:6 del 12/07/2012

Caída desde máximo

-89,63%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,20%

Cierre anterior

18,32

Rango de hoy

18,29 – 18,81

Volumen hoy

1.397.929

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,44%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 11 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/11/1997 52,50 52,50 49,50 52,50 -4,11% 5,71% 6.600
06/11/1997 57,00 57,00 54,00 54,75 -2,01% 5,26% 13.350
05/11/1997 56,25 59,25 54,00 55,88 +4,93% 9,33% 47.867
04/11/1997 48,00 53,25 48,00 53,25 +7,58% 10,94% 6.350
03/11/1997 48,00 50,25 48,00 49,50 +0,00% 4,69% 3.450
31/10/1997 50,06 50,25 48,00 49,50 -0,75% 4,49% 3.583
30/10/1997 48,00 49,88 47,63 49,88 -0,75% 4,69% 3.467
29/10/1997 47,25 50,25 47,25 50,25 +8,06% 6,35% 7.800
28/10/1997 44,25 46,50 40,78 46,50 +2,48% 12,92% 13.217
27/10/1997 51,00 51,00 45,00 45,38 -12,32% 11,76% 7.333
24/10/1997 52,50 54,00 51,75 51,75 -1,43% 4,29% 7.683
23/10/1997 53,25 54,00 51,00 52,50 -5,41% 5,63% 8.217
22/10/1997 54,00 56,25 53,25 55,50 +2,78% 5,56% 13.183
21/10/1997 52,50 54,75 52,50 54,00 +2,86% 4,29% 9.283
20/10/1997 53,25 53,63 51,75 52,50 +1,45% 3,52% 7.417
17/10/1997 53,63 53,63 51,38 51,75 -3,50% 4,20% 9.333
16/10/1997 54,75 54,75 52,50 53,63 -0,69% 4,11% 7.667
15/10/1997 52,50 54,75 52,50 54,00 +2,86% 4,29% 3.283
14/10/1997 54,38 54,38 51,00 52,50 -4,11% 6,21% 5.033
13/10/1997 54,75 55,50 54,00 54,75 +0,00% 2,74% 10.033
10/10/1997 53,63 56,25 52,88 54,75 +2,82% 6,29% 12.750
09/10/1997 56,25 56,25 52,50 53,25 -4,05% 6,67% 25.617
08/10/1997 57,38 57,75 52,88 55,50 -2,63% 8,50% 30.633
07/10/1997 54,75 59,25 53,63 57,00 +6,29% 10,27% 52.350
06/10/1997 51,75 55,13 50,25 53,63 +8,33% 9,42% 46.233
03/10/1997 45,00 51,00 44,63 49,50 +10,92% 14,17% 19.600
02/10/1997 45,00 45,75 44,25 44,63 +0,00% 3,33% 14.200
01/10/1997 42,38 44,63 42,00 44,63 +3,48% 6,19% 5.233
30/09/1997 45,00 45,00 42,38 43,13 -2,54% 5,83% 8.533
29/09/1997 45,00 45,00 44,25 44,25 -1,67% 1,67% 3.233